drugset / Trial / NCT01247103

Assessment of the Safety and Pharmacokinetics of Single and Multiple Oral Doses of AZD4316 in Healthy Subjects

NCT01247103 ↗

Phase 1 Withdrawn 128 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindBasic science

Summary

The purpose of the study is to assess the safety, tolerability and pharmacokinetics of AZD4316 following oral administration of single and multiple doses to healthy volunteers.

Timeline

Start
2010-12
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator AZD4316 Small molecule — Oral

Indications

No indication recorded.